Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination
- PMID: 35496775
- PMCID: PMC9034829
- DOI: 10.1016/j.bbih.2022.100463
Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination
Abstract
Vaccination is an essential public health strategy to control the 2019 Coronavirus (COVID-19) pandemic. While the benefits of the COVID-19 vaccines far outweigh the risks, side effects continue to be reported in the literature. We report a 65-year-old man who developed cognitive deficits and memory impairments following his first dose of Oxford AstraZeneca vaccine (Covishield). The onset of acute cognitive deficits and memory impairments could be another complication to COVID-19 vaccination that physicians and neurologists need to be warned to. Monitoring the safety of COVID-19 vaccines and describing side effects associated with them is essential to improve safety profiles and enhance public trust.
Keywords: COVID-19; Cognitive deficits; Coronavirus; SARS-CoV; Vaccination.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report.JNMA J Nepal Med Assoc. 2021 Aug 12;59(240):805-807. doi: 10.31729/jnma.6454. JNMA J Nepal Med Assoc. 2021. PMID: 34508485 Free PMC article.
-
Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.Sci Rep. 2024 Aug 13;14(1):18767. doi: 10.1038/s41598-024-66999-7. Sci Rep. 2024. PMID: 39138276 Free PMC article.
-
Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.J Med Case Rep. 2022 May 7;16(1):182. doi: 10.1186/s13256-022-03407-6. J Med Case Rep. 2022. PMID: 35524323 Free PMC article.
-
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.Expert Rev Vaccines. 2022 Oct;21(10):1377-1394. doi: 10.1080/14760584.2022.2116008. Epub 2022 Aug 24. Expert Rev Vaccines. 2022. PMID: 35986451 Review.
-
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.Ther Adv Drug Saf. 2023 May 21;14:20420986231165674. doi: 10.1177/20420986231165674. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37223456 Free PMC article. Review.
Cited by
-
The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury.Adv Virol. 2025 Jun 24;2025:7990876. doi: 10.1155/av/7990876. eCollection 2025. Adv Virol. 2025. PMID: 40599824 Free PMC article. Review.
-
Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.Vaccines (Basel). 2024 May 24;12(6):575. doi: 10.3390/vaccines12060575. Vaccines (Basel). 2024. PMID: 38932303 Free PMC article. Review.
-
Spinal Vascular Shunts: Single-Center Series and Review of the Literature of Their Classification.Neurol Int. 2022 Jul 15;14(3):581-599. doi: 10.3390/neurolint14030047. Neurol Int. 2022. PMID: 35893282 Free PMC article.
-
A comprehensive survey on the beliefs, perceptions, and clinical manifestations of pre and post Covid-19 vaccinations among physiotherapy students in the United Arab Emirates.PLoS One. 2023 Apr 13;18(4):e0282385. doi: 10.1371/journal.pone.0282385. eCollection 2023. PLoS One. 2023. PMID: 37053182 Free PMC article.
-
Cognitive Dysfunction in Hospitalized Patient with Moderate-to-Severe COVID-19: A 1-Year Prospective Observational Study.J Multidiscip Healthc. 2023 Nov 8;16:3367-3378. doi: 10.2147/JMDH.S432969. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 38024129 Free PMC article.
References
-
- Blauenfeldt R.A., Kristensen S.R., Ernstsen S.L., Kristensen C.C.H., Simonsen C.Z., Hvas A.M. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J. Thromb. Haemostasis. 2021;19(7):1771–1775. doi: 10.1111/jth.15347. - DOI - PMC - PubMed
-
- Di Carlo D.T., Montemurro N., Petrella G., Siciliano G., Ceravolo R., Perrini P. Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature. J. Neurol. 2021;268(5):1561–1569. doi: 10.1007/s00415-020-09978-y. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous